Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07139912

Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology Reconstruction

Prospective, Multicenter, Single-Arm Trial Assessing Safety/Effectiveness of Multi-Branch Thoracic Stent Grafts in Aortic Arch Disease

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A prospective ,multiple center Study about the Safety and Efficacy of the Thoracic Aortic Multi-Branch Stent Graft System, developed and manufactured by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., in patients with aortic arch pathologies.

Conditions

Interventions

TypeNameDescription
DEVICEThoracic Aortic Multi-Branch Stent Graft SystemThe Thoracic Aortic Multi-Branch Stent Graft Systemm consists of the Single-Branch Aortic Stent-Graft System, the aortic extension stent graft system and the branch stent system.

Timeline

Start date
2025-09-01
Primary completion
2028-03-01
Completion
2032-03-01
First posted
2025-08-24
Last updated
2025-08-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07139912. Inclusion in this directory is not an endorsement.

Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology Reconstruction (NCT07139912) · Clinical Trials Directory